K. Biber, A. Pinto-duarte, M. C. Wittendorp, A. M. Dolga, C. C. Fernandes et al., Interleukin-6 Upregulates Neuronal Adenosine A1 Receptors: Implications for Neuromodulation and Neuroprotection, Neuropsychopharmacology, vol.11, issue.9, pp.2237-2250, 2008.
DOI : 10.1517/14728214.8.2.537

D. Boison, J. F. Chen, and B. B. Fredholm, Adenosine signaling and function in glial cells, Cell Death and Differentiation, vol.939, issue.7, pp.1071-1082, 2010.
DOI : 10.1074/jbc.272.30.18518

G. Burnstock, B. B. Fredholm, and A. Verkhratsky, Adenosine and ATP Receptors in the Brain, Current Topics in Medicinal Chemistry, vol.11, issue.8, pp.973-1011, 2011.
DOI : 10.2174/156802611795347627

A. E. Cardona, E. P. Pioro, M. E. Sasse, V. Kostenko, S. M. Cardona et al., Control of microglial neurotoxicity by the fractalkine receptor, Nature Neuroscience, vol.24, issue.7, pp.917-924, 1996.
DOI : 10.1038/nn1715

M. Catalano, C. Lauro, R. Cipriani, G. Chece, A. Ponzetta et al., CX3CL1 protects neurons against excitotoxicity enhancing GLT-1 activity on astrocytes, Journal of Neuroimmunology, vol.263, issue.1-2, pp.75-82, 2013.
DOI : 10.1016/j.jneuroim.2013.07.020
URL : https://hal.archives-ouvertes.fr/pasteur-01053833

G. A. Chapman, K. Moores, D. Harrison, C. A. Campbell, B. R. Stewart et al., Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage, J. Neurosci, vol.20, pp.87-91, 2000.

G. J. Chen, B. K. Harvey, H. Shen, J. Chou, A. Victor et al., Activation of adenosine A3 receptors reduces ischemic brain injury in rodents, Journal of Neuroscience Research, vol.23, issue.8, pp.1848-1855, 2006.
DOI : 10.1002/jnr.21071

C. J. Chen, S. L. Liao, and J. S. Kuo, Gliotoxic Action of Glutamate on Cultured Astrocytes, Journal of Neurochemistry, vol.1, issue.4, 2000.
DOI : 10.1046/j.1471-4159.2000.0751557.x

R. Cipriani, P. Villa, G. Chece, C. Lauro, A. Paladini et al., CX3CL1 Is Neuroprotective in Permanent Focal Cerebral Ischemia in Rodents, Journal of Neuroscience, vol.31, issue.45, pp.16327-16335, 2011.
DOI : 10.1523/JNEUROSCI.3611-11.2011

A. Dénes, S. Ferenczi, J. Halász, Z. Környei, and K. J. Kovács, Role of CX3CR1 (Fractalkine Receptor) in Brain Damage and Inflammation Induced by Focal Cerebral Ischemia in Mouse, Journal of Cerebral Blood Flow & Metabolism, vol.26, issue.10, pp.1707-172164, 2008.
DOI : 10.1016/S0165-5728(99)00202-7

I. M. Fedorova, M. A. Jacobson, A. Basile, and K. A. Jacobson, Behavioral characterization of mice lacking the A3 adenosine receptor: sensitivity to hypoxic neurodegeneration, Cellular and Molecular Neurobiology, vol.23, issue.3, pp.431-447, 2003.
DOI : 10.1023/A:1023601007518

H. Franke, A. Verkhratsky, G. Burnstock, and P. Illes, Pathophysiology of astroglial purinergic signalling, Purinergic Signalling, vol.127, issue.1, pp.629-657, 2012.
DOI : 10.1007/s11302-012-9300-0

M. Fuhrmann, T. Bittner, C. K. Jung, S. Burgold, R. M. Page et al., Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease, Nature Neuroscience, vol.20, issue.4, pp.411-413, 2010.
DOI : 10.1038/nn.2511

P. J. Gough, K. J. Garton, P. T. Wille, M. Rychlewski, P. J. Dempsey et al., A Disintegrin and Metalloproteinase 10-Mediated Cleavage and Shedding Regulates the Cell Surface Expression of CXC Chemokine Ligand 16, The Journal of Immunology, vol.172, issue.6, pp.3678-3685, 2004.
DOI : 10.4049/jimmunol.172.6.3678

P. J. Hallett and D. G. Standaert, Rationale for and use of NMDA receptor antagonists in Parkinson's disease, Pharmacology & Therapeutics, vol.102, issue.2, pp.155-174, 2004.
DOI : 10.1016/j.pharmthera.2004.04.001

M. E. Hamby and M. V. Sofroniew, Reactive astrocytes as therapeutic targets for CNS disorders, Neurotherapeutics, vol.2, issue.Suppl 8, pp.494-506, 2010.
DOI : 10.1016/j.nurt.2010.07.003

D. Huang, F. D. Shi, S. Jung, G. C. Pien, J. Wang et al., The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system Stroke research at a crossroad: asking the brain for directions, FASEB J. Nat. Neurosci, vol.20, issue.14, pp.896-905, 2006.

C. Lauro, R. Cipriani, M. Catalano, F. Trettel, G. Chece et al., Adenosine A1 Receptors and Microglial Cells Mediate CX3CL1-Induced Protection of Hippocampal Neurons Against Glu-Induced Death, Neuropsychopharmacology, vol.104, issue.7, pp.1550-1559, 2010.
DOI : 10.1016/S0165-5728(01)00259-4
URL : https://hal.archives-ouvertes.fr/hal-00514619

S. Lee, N. H. Varvel, M. E. Konerth, G. Xu, A. E. Cardona et al., CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models, The American Journal of Pathology, vol.177, issue.5, pp.2549-2562, 2010.
DOI : 10.2353/ajpath.2010.100265

C. Limatola, C. Lauro, M. Catalano, M. T. Ciotti, C. Bertollini et al., Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity, Journal of Neuroimmunology, vol.166, issue.1-2, pp.19-28, 2005.
DOI : 10.1016/j.jneuroim.2005.03.023

S. A. Lipton, The Molecular Basis of Memantine Action in Alzheimers Disease and Other Neurologic Disorders: Low-affinity, Uncompetitive Antagonism, Current Alzheimer Research, vol.2, issue.2, pp.155-165, 2005.
DOI : 10.2174/1567205053585846

W. Liu, Y. Tang, and J. Feng, Cross talk between activation of microglia and astrocytes in pathological conditions in the central nervous system, Life Sciences, vol.89, issue.5-6, pp.141-146, 2011.
DOI : 10.1016/j.lfs.2011.05.011

S. Moidunny, R. B. Dias, E. Wesseling, Y. Sekino, H. W. Boddeke et al., Interleukin-6-type cytokines in neuroprotection and neuromodulation: oncostatin M, but not leukemia inhibitory factor, requires neuronal adenosine A1 receptor function, Journal of Neurochemistry, vol.387, issue.1, pp.1667-1677, 2010.
DOI : 10.1111/j.1471-4159.2010.06881.x

M. A. Moskowitz, E. H. Lo, and C. Iadecola, The Science of Stroke: Mechanisms in Search of Treatments, Neuron, vol.68, issue.1, 2010.
DOI : 10.1016/j.neuron.2010.08.019

M. Noda, Y. Doi, J. Liang, J. Kawanokuchi, Y. Sonobe et al., Fractalkine Attenuates Excito-neurotoxicity via Microglial Clearance of Damaged Neurons and Antioxidant Enzyme Heme Oxygenase-1 Expression, Journal of Biological Chemistry, vol.286, issue.3, pp.2308-2319, 2011.
DOI : 10.1074/jbc.M110.169839

O. Pascual, B. Achour, S. Rostaing, P. Triller, A. Bessis et al., Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission, Proceedings of the National Academy of Sciences, vol.109, issue.4, pp.197-205, 2012.
DOI : 10.1073/pnas.1111098109

G. Paxinos, F. , and K. B. , The Mouse Brain in Stereotoxic Coordinates, 2004.

A. Pupovac, C. M. Foster, and R. Sluyter, Human P2X7 receptor activation induces the rapid shedding of CXCL16, Biochemical and Biophysical Research Communications, vol.432, issue.4, 2013.
DOI : 10.1016/j.bbrc.2013.01.134

M. Rosito, C. Deflorio, C. Limatola, and F. Trettel, CXCL16 Orchestrates Adenosine A3 Receptor and MCP-1/CCL2 Activity to Protect Neurons from Excitotoxic Cell Death in the CNS, Journal of Neuroscience, vol.32, issue.9, pp.3154-3163, 2012.
DOI : 10.1523/JNEUROSCI.4046-11.2012
URL : https://hal.archives-ouvertes.fr/pasteur-00961616

C. A. Salvatore, S. L. Tilley, A. M. Latour, D. S. Fletcher, B. H. Koller et al., Disruption of the A3 Adenosine Receptor Gene in Mice and Its Effect on Stimulated Inflammatory Cells, Journal of Biological Chemistry, vol.275, issue.6, pp.4429-4434, 2000.
DOI : 10.1074/jbc.275.6.4429

T. D. Schmittgen and K. J. Livak, Analyzing real-time PCR data by the comparative CT method, Nature Protocols, vol.2, issue.6, pp.1101-110873, 2008.
DOI : 10.1038/nprot.2008.73

P. J. Shaw, V. Forrest, P. G. Ince, J. P. Richardson, and H. J. Wastell, CSF and Plasma Amino Acid Levels in Motor Neuron Disease: Elevation of CSF Glutamate in a Subset of Patients, Neurodegeneration, vol.4, issue.2, pp.209-2160026, 1995.
DOI : 10.1006/neur.1995.0026

S. G. Soriano, L. S. Amaravadi, Y. F. Wang, H. Zhou, G. X. Yu et al., Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury, Journal of Neuroimmunology, vol.125, issue.1-2, pp.59-65, 2002.
DOI : 10.1016/S0165-5728(02)00033-4

C. Storini, L. Bergamaschini, R. Gesuete, E. Rossi, D. Maiocchi et al., Selective Inhibition of Plasma Kallikrein Protects Brain from Reperfusion Injury, Journal of Pharmacology and Experimental Therapeutics, vol.318, issue.2, pp.849-854, 2006.
DOI : 10.1124/jpet.106.105064

T. Suzuki, I. Hide, K. Ido, S. Kohsaka, K. Inoue et al., Production and Release of Neuroprotective Tumor Necrosis Factor by P2X7 Receptor-Activated Microglia, Journal of Neuroscience, vol.24, issue.1, pp.1-7, 2004.
DOI : 10.1523/JNEUROSCI.3792-03.2004

G. Tarozzo, M. Campanella, M. Ghiani, A. Bulfone, and M. Beltramo, CR1, in response to ischaemia-reperfusion brain injury in the rat, European Journal of Neuroscience, vol.65, issue.10, pp.1663-1668, 2002.
DOI : 10.1002/(sici)1097-4547(19980701)53:1<16::aid-jnr3>3.3.co;2-0

D. Unutmaz, W. Xiang, M. J. Sunshine, J. Campbell, E. Butcher et al., The Primate Lentiviral Receptor Bonzo/STRL33 Is Coordinately Regulated with CCR5 and Its Expression Pattern Is Conserved Between Human and Mouse, The Journal of Immunology, vol.165, issue.6, pp.3284-3292, 2000.
DOI : 10.4049/jimmunol.165.6.3284
URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.326.7092

C. Ciotti, M. T. Battistini, and L. , Development of a method for measuring cell number: application to CNS primary neuronal cultures, Frontiers in Cellular Neuroscience www.frontiersin.org Volontè, pp.274-276, 1994.

J. Zhu, Z. Zhou, Y. Liu, and J. Zheng, Fractalkine and CX3CR1 are involved in the migration of intravenously grafted human bone marrow stromal cells toward ischemic brain lesion in rats, Glutamate release and cerebral blood flow after severe human head injury, pp.40-44, 2009.
DOI : 10.1016/j.brainres.2009.06.068